Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma

Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma

IntroductionPancreatic cancer is a truculent disease with limited treatment options and a grim prognosis. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness in pancreatic cancer has been lacking. As a result, it is crucial to identify markers associated with i...

Full description

Bibliographic Details
Main Authors: Fereshteh Rezagholizadeh, Fatemeh Tajik, Morteza Talebi, Seyed Reza Taha, Mahdieh Shariat Zadeh, Pooya Farhangnia, Hamideh Sadat Hosseini, Aram Nazari, Shabnam Mollazadeh Ghomi, Seyede Mahtab Kamrani Mousavi, Niloofar Haeri Moghaddam, Hossein Khorramdelazad, Mohammad Taghi Joghataei, Elahe Safari
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
VISTA
PDAC
CD68
pancreatic ductal adenocarcinoma
prognosis
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1283364/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1283364/full

Similar Items